CRP and depressive symptom measurement: A double-blind, placebo-controlled, randomized clinical trial in treatment resistant depression found that infusions of infliximab significantly reduced scores on the HAM-D at week 12 in patients with a baseline CRP concentration greater than 5 mg/L (154).